Author:
Esquivel-Hernández Diego A.,Martínez-López Yoscelina Estrella,Sánchez-Castañeda Jean Paul,Neri-Rosario Daniel,Padrón-Manrique Cristian,Giron-Villalobos David,Mendoza-Ortíz Cristian,Resendis-Antonio Osbaldo
Abstract
IntroductionThe human gut microbiota (GM) is a dynamic system which ecological interactions among the community members affect the host metabolism. Understanding the principles that rule the bidirectional communication between GM and its host, is one of the most valuable enterprise for uncovering how bacterial ecology influences the clinical variables in the host.MethodsHere, we used SparCC to infer association networks in 16S rRNA gene amplicon data from the GM of a cohort of Mexican patients with type 2 diabetes (T2D) in different stages: NG (normoglycemic), IFG (impaired fasting glucose), IGT (impaired glucose tolerance), IFG + IGT (impaired fasting glucose plus impaired glucose tolerance), T2D and T2D treated (T2D with a 5-year ongoing treatment).ResultsBy exploring the network topology from the different stages of T2D, we observed that, as the disease progress, the networks lose the association between bacteria. It suggests that the microbial community becomes highly sensitive to perturbations in individuals with T2D. With the purpose to identify those genera that guide this transition, we computationally found keystone taxa (driver nodes) and core genera for a Mexican T2D cohort. Altogether, we suggest a set of genera driving the progress of the T2D in a Mexican cohort, among them Ruminococcaceae NK4A214 group, Ruminococcaceae UCG-010, Ruminococcaceae UCG-002, Ruminococcaceae UCG-005, Alistipes, Anaerostipes, and Terrisporobacter.DiscussionBased on a network approach, this study suggests a set of genera that can serve as a potential biomarker to distinguish the distinct degree of advances in T2D for a Mexican cohort of patients. Beyond limiting our conclusion to one population, we present a computational pipeline to link ecological networks and clinical stages in T2D, and desirable aim to advance in the field of precision medicine.
Funder
Consejo Nacional de Ciencia y Tecnología
Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México
Instituto Nacional de Medicina Genómica
Subject
Endocrinology, Diabetes and Metabolism
Reference96 articles.
1. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives;Reed;Diabetes Metab Syndrome Obesity: Targets Ther Volume,2021
2. Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era;Martínez-López;Gut Microbes,2022
3. Novel biomarkers for prediabetes, diabetes, and associated complications;Dorcely;Diabetes Metab syndrome obesity: Targets Ther,2017
4. The gut microbiota in prediabetes and diabetes: A population-based cross-sectional study;Wu;Cell Metab,2020
5. Prediabetes and lifestyle modification: time to prevent a preventable disease;Tuso;Permanente J,2014